These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 27340285)

  • 1. Inflammation and Progression of CKD: The CRIC Study.
    Amdur RL; Feldman HI; Gupta J; Yang W; Kanetsky P; Shlipak M; Rahman M; Lash JP; Townsend RR; Ojo A; Roy-Chaudhury A; Go AS; Joffe M; He J; Balakrishnan VS; Kimmel PL; Kusek JW; Raj DS;
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1546-1556. PubMed ID: 27340285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.
    Gupta J; Mitra N; Kanetsky PA; Devaney J; Wing MR; Reilly M; Shah VO; Balakrishnan VS; Guzman NJ; Girndt M; Periera BG; Feldman HI; Kusek JW; Joffe MM; Raj DS;
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):1938-46. PubMed ID: 23024164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
    Amdur RL; Feldman HI; Dominic EA; Anderson AH; Beddhu S; Rahman M; Wolf M; Reilly M; Ojo A; Townsend RR; Go AS; He J; Xie D; Thompson S; Budoff M; Kasner S; Kimmel PL; Kusek JW; Raj DS;
    Am J Kidney Dis; 2019 Mar; 73(3):344-353. PubMed ID: 30545708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the chronic renal insufficiency cohort study.
    Wing MR; Yang W; Teal V; Navaneethan S; Tao K; Ojo A; Guzman NN; Reilly M; Wolman M; Rosas SE; Cuevas M; Fischer M; Lustigova E; Master SR; Xie D; Appleby D; Joffe M; Kusek J; Feldman HI; Raj DS;
    Obesity (Silver Spring); 2014 May; 22(5):1359-66. PubMed ID: 24415732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
    Bowe B; Xie Y; Xian H; Li T; Al-Aly Z
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):603-613. PubMed ID: 28348030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study.
    Amdur RL; Mukherjee M; Go A; Barrows IR; Ramezani A; Shoji J; Reilly MP; Gnanaraj J; Deo R; Roas S; Keane M; Master S; Teal V; Soliman EZ; Yang P; Feldman H; Kusek JW; Tracy CM; Raj DS;
    PLoS One; 2016; 11(2):e0148189. PubMed ID: 26840403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not all inflammatory markers are linked to kidney function: results from a population-based study.
    Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
    Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.
    Lee BT; Ahmed FA; Hamm LL; Teran FJ; Chen CS; Liu Y; Shah K; Rifai N; Batuman V; Simon EE; He J; Chen J
    BMC Nephrol; 2015 May; 16():77. PubMed ID: 26025192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD.
    Weiner DE; Tighiouart H; Elsayed EF; Griffith JL; Salem DN; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2008 Feb; 51(2):212-23. PubMed ID: 18215699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
    Bash LD; Erlinger TP; Coresh J; Marsh-Manzi J; Folsom AR; Astor BC
    Am J Kidney Dis; 2009 Apr; 53(4):596-605. PubMed ID: 19110358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum anion gap in adults with moderate chronic kidney disease increases risk for progression to end-stage renal disease.
    Banerjee T; Crews DC; Wesson DE; McCulloch CE; Johansen KL; Saydah S; Rios Burrows N; Saran R; Gillespie B; Bragg-Gresham J; Powe NR
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1244-F1253. PubMed ID: 30908932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
    Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
    Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
    Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
    Sun J; Axelsson J; Machowska A; Heimbürger O; Bárány P; Lindholm B; Lindström K; Stenvinkel P; Qureshi AR
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1163-1172. PubMed ID: 27281698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.
    Seiler-Mussler S; Limbach AS; Emrich IE; Pickering JW; Roth HJ; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):569-576. PubMed ID: 29507005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Markers and Incidence of Hospitalization With Infection in Chronic Kidney Disease.
    Ishigami J; Taliercio J; I Feldman H; Srivastava A; Townsend R; L Cohen D; Horwitz E; Rao P; Charleston J; Fink JC; Ricardo AC; Sondheimer J; Chen TK; Wolf M; Isakova T; Appel LJ; Matsushita K;
    Am J Epidemiol; 2020 May; 189(5):433-444. PubMed ID: 31673705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Homocysteine Is a Predictive Factor for Accelerated Renal Function Decline and Chronic Kidney Disease in a Community-Dwelling Population.
    Xiao W; Ye P; Wang F; Cao R; Bai Y; Wang X
    Kidney Blood Press Res; 2021; 46(5):541-549. PubMed ID: 34365457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.
    Rahman M; Yang W; Akkina S; Alper A; Anderson AH; Appel LJ; He J; Raj DS; Schelling J; Strauss L; Teal V; Rader DJ;
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1190-8. PubMed ID: 24832097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.